BERLIN (Reuters) -CureVac will withdraw its first-generation COVID-19 vaccine candidate and focus on collaborating with GSK to develop second-generation mRNA […]
CureVac crashes after crucial COVID-19 vaccine trial disappoints
(Reuters) – CureVac shares fell by as much as 52% on Thursday after the German biotech’s COVID-19 vaccine proved only […]
CureVac says aiming for pivotal vaccine trial read-out early in second quarter
FILE PHOTO: A dose of CureVac vaccine or a placebo is seen during a study by the German biotech firm […]